Molecular Testing for Bethesda III Thyroid Nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution

Stillman, M., Kuo, E. J., Liou, R., Almuqate, A., Virk, R., Lee, J. A., Kuo, J. H., & McManus, C. M. (2024). Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution. Thyroid®. https://doi.org/10.1089/thy.2023.0664
Authors:
Mason D Stillman
Eric J Kuo
Rachel Liou
Abdullah Almuqate
Renu Virk
James A Lee
Jennifer H Kuo
Catherine M McManus
Affiliated Authors:
Mason D Stillman
Eric J Kuo
Rachel Liou
Abdullah Almuqate
Renu Virk
James A Lee
Jennifer H Kuo
Catherine M McManus
Subjects:
Author Keywords:
thyroid
cancer
molecular testing
cytopathology
surgery
Publication Type:
Article
Unique ID:
10.1089/thy.2023.0664
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: